“…Considering continuous twin screw granulation, initial studies mainly focused on the effect of process settings [ 49 , 50 , 51 ] and screw configurations [ 52 , 53 , 54 ]. However, more recent studies have highlighted the importance of formulation and raw material properties [ 2 , 12 , 27 , 46 , 47 , 55 , 56 , 57 , 58 , 59 , 60 , 61 ] and aspects related to drug product registration such as PAT implementation and control strategies [ 7 , 10 , 62 ]. Since most of the studies on twin screw wet granulation focus on a single formulation, often not containing an active pharmaceutical ingredient (API), results are difficult to generalize.…”